Abstract
Nature Clinical Practice Rheumatology (2009) 5: 20–27 [doi:10.1038/ncprheum0977] In the January 2009 issue, in the Review by Deal, the randomized controlled trial evaluating four doses of odanacatib was described incorrectly on page 22. In this trial odanacatib was given weekly, not daily. There wasalso an error in the corresponding author's email address.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
